Science and Technology

Bio-manufacturing uses living cells, enzymes, or biological systems to produce materials, chemicals, foods, and medicines. Fermentation-based production is a core pillar of this field, relying on microorganisms such as bacteria, yeast, and fungi to convert feedstocks into valuable outputs. Once limited mainly to pharmaceuticals and food ingredients, these approaches are now expanding into fuels, materials, agriculture, and consumer goods. Several powerful trends are accelerating this shift.Climate Pressure and the Push for Low-Carbon ManufacturingA major force behind this shift is the worldwide imperative to cut greenhouse gas emissions and lessen resource consumption, as conventional petrochemical production relies heavily on fossil inputs…

Neural Processing Units, commonly called NPUs, are specialized processors designed to accelerate artificial intelligence and machine learning workloads. Unlike CPUs, which handle general-purpose tasks, or GPUs, which excel at parallel graphics and compute operations, NPUs focus on matrix math, inference, and on-device learning with extreme efficiency. Alongside NPUs, the broader category of AI chips includes dedicated accelerators integrated into system-on-a-chip designs or offered as discrete components in PCs and servers.Over the last half decade, AI workloads have steadily moved away from cloud‑first computation and toward on-device intelligence. This transition is fueled by calls for reduced latency, heightened privacy, and improved…

Artificial intelligence is swiftly shifting from small-scale trials to essential, high-stakes applications within regulated fields like finance, healthcare, energy, telecommunications, insurance, and pharmaceuticals, and as AI increasingly shapes decisions carrying legal, ethical, and social consequences, oversight has ceased to be optional and is instead evolving into a fundamental obligation driven by regulatory pressure, risk mitigation, and public responsibility.The Growing Influence of AI Across Critical Operational SettingsRegulated industries are increasingly leveraging AI to boost efficiency, enhance precision, and expand operational capacity; for instance, banks rely on credit assessment models, healthcare uses diagnostic algorithms, insurance firms deploy fraud‑detection systems, capital markets employ…

Personalized medicine seeks to adjust prevention, diagnosis, and treatment to each patient’s distinct biological makeup, environmental context, and lifestyle habits, and over the past decade this vision has steadily shifted into routine practice, influencing how therapies are created and how clinical trials take shape. Progress in genomics, data science, and digital health continues to drive this evolution, while regulatory bodies and healthcare institutions adapt to encourage more precise, individualized, and patient-focused research frameworks.Genomics and Multi-Omics as Cornerstones of ProgressThe dramatic decrease in genome sequencing expenses, combined with the growing adoption of multi-omics techniques, has profoundly reshaped personalized medicine.Genomics: Through whole-genome…

Drug discovery has traditionally been a slow, expensive, and high-risk process, often taking more than a decade and billions of dollars to bring a single therapy to market. Recent advances in artificial intelligence and protein folding tools are reshaping this landscape by dramatically improving how scientists understand biological targets, design drug candidates, and predict outcomes. Together, these technologies are compressing timelines, lowering costs, and opening therapeutic opportunities that were previously out of reach.The Essential Importance of Protein Architecture in Contemporary Drug DevelopmentMost medications exert their effects by attaching to specific proteins and modifying how those proteins function, and creating potent…

Digital biomarkers are objective, quantifiable physiological and behavioral data collected through digital devices such as smartphones, wearable sensors, and connected medical tools. Unlike traditional biomarkers, which often rely on laboratory tests or in-clinic measurements, digital biomarkers are generated continuously in real-world settings. They capture signals like heart rhythm, physical activity, sleep patterns, voice characteristics, typing behavior, and movement dynamics, transforming everyday interactions with technology into health insights.From Episodic Care to Continuous MonitoringConventional health checkups usually occur sporadically through infrequent clinic appointments and brief diagnostic evaluations, while digital biomarkers move this approach toward ongoing monitoring. Around-the-clock tracking from wearable devices can…

Zero-knowledge proofs, or ZKPs, first emerged within academic cryptography and later entered the public spotlight through blockchain technology and privacy-driven cryptocurrencies. Their fundamental appeal lies in a remarkable idea: a party can verify the truth of a claim without disclosing the data that substantiates it. As organizations confront increasing demands to safeguard confidential information, meet rigorous regulatory requirements, and still operate collaboratively across different entities, this approach is becoming valuable well beyond digital asset ecosystems.A hands-on perspective on zero-knowledge proofsAt an enterprise level, ZKPs enable verifiable trust with minimal disclosure. Instead of sharing raw data, organizations can share proofs that…